Pregabalin Linked to Higher Heart Failure Risk Compared to Gabapentin: JAMA
Written By : Dr. Shravani Dali
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-09-09 15:15 GMT | Update On 2025-09-10 06:20 GMT
Advertisement
A new retrospective cohort study published in JAMA Internal Medicine has found that pregabalin, a commonly prescribed nonopioid analgesic, is associated with a significantly higher risk of heart failure events compared to gabapentin.
The study analyzed Medicare claims data from a large population of older adults and observed that patients initiated on pregabalin had an elevated incidence of hospitalization due to heart failure.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.